Molecular targets of current and prospective heart failure therapies.
about
Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Cyclic ADP-Ribose (cADPR) Mediate Ca2+ Signaling in Cardiac Hypertrophy Induced by β-Adrenergic Stimulation.Triptolide Upregulates Myocardial Forkhead Helix Transcription Factor p3 Expression and Attenuates Cardiac Hypertrophy.The Notch pathway: a novel target for myocardial remodelling therapy?Cardiac gene therapy with adeno-associated virus-based vectors.Almanac 2013: heart failure.
P2860
Molecular targets of current and prospective heart failure therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular targets of current and prospective heart failure therapies.
@en
type
label
Molecular targets of current and prospective heart failure therapies.
@en
prefLabel
Molecular targets of current and prospective heart failure therapies.
@en
P2860
P1433
P1476
Molecular targets of current and prospective heart failure therapies.
@en
P2093
Elie R Chemaly
Roger J Hajjar
P2860
P304
P356
10.1136/HEARTJNL-2012-302970
P407
P577
2013-01-24T00:00:00Z